805 filings
Page 4 of 41
8-A12B/A
03immjd migjn0g74
12 Feb 21
Registration of securities on exchange (amended)
9:22am
8-K
soeervhen yzmltw
12 Feb 21
Vericel Announces Termination of Shareholder Rights Agreement
8:56am
8-K
wqdoe
25 Jan 21
Vericel Announces Appointment of Joe Mara as Chief Financial Officer
8:35am
8-K
eklwae8b2f2cqkllpeui
11 Jan 21
Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020 Financial Results and Provides Business Updates
7:30am
8-K
b6duvqcp19b64mo6m
5 Nov 20
Vericel Reports Record Third Quarter Revenues and Net Income
9:27am
8-K
8emz6 o2dl8gj
14 Oct 20
Vericel Announces Preliminary Third Quarter 2020 Total Net Revenues of $32 Million
8:00am
8-K
gtkzk 94nj
16 Sep 20
Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns
4:05pm
8-K
ta8492wmh
8 Sep 20
Departure of Directors or Certain Officers
4:04pm
S-8
qq5o9xt6l 9jxlpc5
6 Aug 20
Registration of securities for employees
5:04pm
8-K
7wxbl2luzy6d8c x7a
5 Aug 20
Vericel Reports Second Quarter 2020 Financial Results
8:45am
8-K
4lqu0orp ij7
9 Jul 20
Vericel Announces Preliminary Second Quarter 2020 Financial Results and Provides Business Updates
4:12pm
8-K
6dgx9s 5a
30 Jun 20
Vericel Announces Submission of Biologics License Application to the FDA for NexoBrid for the Treatment of Severe Thermal Burns
4:08pm
8-K
1qpvys1o
5 May 20
Vericel Reports First Quarter 2020 Financial Results
8:19am
8-K
nqao9
1 May 20
Departure of Directors or Certain Officers
4:10pm
DEFA14A
qsb3ua lwr
10 Apr 20
Additional proxy soliciting materials
9:10am
8-K
3tyg hsdu
2 Apr 20
Vericel Provides Business and Financial Updates
9:02am